Global HIV Drugs Sales Market 2018 Analysis, Size, Share, Growth, Trends and Forecast To 2025

Global HIV Drugs Sales Market 2018 Analysis, Size, Share, Growth, Trends and Forecast To 2025

Global HIV Drugs Sales Market is a fastest developing market at present years. The HIV Drugs Sales market has enfolded a rapid growth in past years and recent years and is potentially moving forward with a persistent progress in the forthcoming years. The Global HIV Drugs Sales Market Report has integrated the succinct analysis and thorough premise of logical data together. […]

Intervention to end HIV mother-to-child infections – Pregnant women to receive drugs at ANCs

Intervention to end HIV mother-to-child infections – Pregnant women to receive drugs at ANCs

The National AIDS/STI Control Programme Manager, Dr Stephen Ayisi Addo has stated that antenatal clinics (ANCs) have been equipped to administer antiretroviral therapy to pregnant women who have tested positive for HIV to prevent mother-to-child transmissions of the disease, which was steadily increasing. “This means that a pregnant woman who has HIV will not be […]

ViiV submits NDA for two-drug HIV regimen

ViiV submits NDA for two-drug HIV regimen

Healio Infectious Disease HIV/AIDS October 18, 2018 Add Topic To Email Alerts ‘); $j(‘.topic-alert-section .dropdown-menu .auth’).hide(); $j(‘.topic-alert-section .dropdown-menu .anon’).hide(); $j(‘.topic-alert-section .dropdown-menu .subscribed’).show(); $j(‘.topic-alert-section .dropdown-menu’).removeClass(‘anon-dropdown’); $j(‘.topic-alert-section .dropdown-menu’).addClass(‘subscribed-dropdown’); $j(“.manage-alerts”).show(); } function TopicListAddSuccess() { $j(“.topic-alert-section”).removeClass(“open”); ShowAddedToAlerts(); AlertMemberAddedToList($j(“.dropdown-topic”).html().trim()); } function AddEmailToTopicList(button) { $j.fn.validator.Constructor.FOCUS_OFFSET = “0px”; […]

Gilead, Aelix ally to trial HIV-suppressing combination

Gilead, Aelix ally to trial HIV-suppressing combination

Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7 agonist in combination with Aelix’s T-cell vaccine.  Gilead began testing the TLR7 agonist, vesatolimod, in HIV patients in 2016. In animal models, the […]

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a …

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a …

BARCELONA, Spain–(BUSINESS WIRE)–Oct 18, 2018–AELIX Therapeutics S.L. (“AELIX”), a clinical-stage biotechnology company specialized in the discovery and development of immunotherapies for HIV infection, today announces that it has entered into a clinical research collaboration with Gilead Sciences, Inc. (“Gilead”), a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical […]

Gilead and Aelix join forces to pursue HIV 'cure'

Gilead and Aelix join forces to pursue HIV 'cure'

Gilead Sciences – already a giant in HIV therapy – has teamed up with Spanish biotech Aelix Therapeutics to try to develop a treatment regimen that would go beyond controlling the virus and provide an effective cure for the infection. The plan is to combine Gilead’s experimental toll-like receptor 7 agonist vesatolimod (GS-9620) – in […]

Integrated support intervention improves engagement with HIV and methadone treatment among people who inject drugs

Integrated support intervention improves engagement with HIV and methadone treatment among people who inject drugs

Providing information on how to navigate care pathways, psychosocial support, and immediate antiretroviral therapy (ART) to HIV-positive people who inject drugs (PWID) in Ukraine, Vietnam and Indonesia increased retention in care, ART use, viral suppression as well as use of methadone and other medication-assisted treatment (MAT) for drug use, according to a randomised trial recently […]

Scientists Nearly Eliminate HIV Reservoirs in Patients Using Stem Cells

Scientists Nearly Eliminate HIV Reservoirs in Patients Using Stem Cells

Tech 23:29 17.10.2018Get short URL Spanish scientists found huge reductions in the HIV-1 (Human Immunodeficiency Virus) reservoirs of five patients who underwent stem cell transplant treatment, according to research published Tuesday in the Annals of Internal Medicine Journal. Latent HIV reservoirs are the cells of the body where HIV is able to persist even when patients are […]